Skip to main content

Table 4 Priorities stratified by site

From: Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis

Variable Aggregate China Japan South Korea Taiwan Chi-squared p-value
  Coef ( SE ) Coef ( SE ) Coef ( SE ) Coef ( SE ) Coef ( SE )  
Monitoring at-risk populations 13.75*** 9.17** 16.67*** 17.08*** 12.08*** 0.20
  (1.5) (3.1) (2.7) (3.3) (2.5)  
Risk Assessment 5.42*** 5.83* 0.83 7.08* 7.92** 0.18
  (1.3) (2.4) (2.4) (2.9) (2.4)  
Access to treatments 5.21*** 10.83*** 5.83* 1.25 2.92 0.11
  (1.4) (3.0) (2.4) (2.7) (3.2)  
National guidelines 8.96*** 14.17*** 10.00*** 7.92** 3.75 0.02*
  (1.4) (2.8) (3.3) (2.7) (2.0)  
Research infrastructure 3.96** 4.17 6.67* 3.75 1.25 0.63
  (1.4) (2.5) (2.8) (2.5) (3)  
Centers of excellence 6.86*** 5.83* 10.00*** 6.25* 5.42* 0.60
  (1.5) (3.9) (2.5) (1.9) (3.1)  
Multidisciplinary management 8.33*** 7.50** 11.67*** 6.25* 7.92** 0.44
  (1.4) (2.4) (2.1) (3.4) (2.7)  
Clinician education 11.04*** 7.50** 10.83*** 15.42*** 10.42*** 0.15
  (1.3) (2.3) (3.2) (2.5) (2.6)  
Public awareness 8.13*** 3.33 6.67* 11.25*** 11.25*** 0.11
  (1.4) (2.7) (2.8) (2.7) (2.6)  
Transplantation infrastructure 0.42 −8.33 5.83 −0.42 4.58 0.01**
  (1.5) (3.6) (2.4) (2.7) (2.7)  
Measuring Social Burden 5.21*** 2.50 2.50 2.92 12.92*** 0.04*
  (1.4) (2.5) (2.7) (2.4) (3.1)  
  1. *p<0.05, **p<0.01, ***p<0.001, aggregate model R 2 =0.269, p<0.001, stratified model R 2 =.320.
\